Candida albicans arthritis in a nonimmuno-compromised patient : Complication of placebo intraarticular injections
A nonimmunocompromised 32-year-old man with arthrosis of the knee participated as a placebo control in a clinical trial of intraarticular injections of hya-luronan. After the fourth weekly injection of saline, he developed a warm and swollen knee, and synovia! fluid cultures revealed growth of Candida albicans. Oral fluconazole treatment was instituted 2 weeks after onset of symptoms, but failed t
